<DOC>
	<DOCNO>NCT02086019</DOCNO>
	<brief_summary>For octogenarian patient NSTEMI ( non-ST segment elevation myocardial infarction ) invasive-guided strategy prove superior conservative strategy respect combine endpoint cause mortality non-fatal myocardial infarction .</brief_summary>
	<brief_title>Revascularisation Medical Therapy Elderly Patients With Acute Anginal Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>AGE &gt; 80 NonSTEMI characteristic chest pain accompany Typical ischaemic ECG change A troponin rise Suitable conservative invasive strategy Lack suitability whatever clinical reason randomise eg dementia , comorbidity Acute STEMI Cardiogenic shock Platelet count =50 x 109/mm3 Patient life expectancy &lt; 1 year Known allergy clopidogrel , aspirin , heparin , stainless steel , IV contrast stent drug elutant Recent major GI haemorrhage ( within 3 month ) Any previous cerebral bleeding episode Participation another investigational drug device study Patient unable give consent Clinical decision precluding use stent</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Revascularisation , octogenarian , acute coronary syndrome</keyword>
</DOC>